 |
|
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures
A. James Rowan, MD;
Jaap W. A. Meijer, PhD;
Nina de Beer-Pawlikowski;
Peter van der Geest;
Harry Meinardi, MD, PhD
Arch Neurol. 1983;40(13):797-802.
Abstract
• Five patients had absence seizures refractory to treatment with either ethosuximide or valproate sodium. To determine their response to combination therapy with the two drugs, four of the five had serial 24-hour intensive monitoring studies that included cable telemetric EEG recording, closed-circuit television observation, and frequent antiepileptic drug (AED) serum level determinations. The resultant data confirmed the clinical and EEG effects of serial alterations in AED programs. All five became seizure free with combination therapy. Combination therapy with ethosuximide and valproate should be considered in patients whose absence seizures do not respond to standard therapeutic measures.
Author Affiliations
From the Mount Sinai School of Medicine and the Bronx Veterans Administration Medical Center, New York (Dr Rowan); and the Instituut voor Epilepsiebestrijding, Heemstede, the Netherlands (Drs Meijer and Meinardi, Ms de Beer-Pawlikowski, and Mr van der Geest).
Footnotes
Accepted for publication July 13, 1982.
Reprint requests to Neurology Service, Veterans Administration Medical Center, 130 W Kingsbridge Rd, Bronx, NY 10468 (Dr Rowan).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues
Sankar
Neurology 2004;63:S30-S39.
ABSTRACT
| FULL TEXT
Staged approach to epilepsy management
Brodie and Kwan
Neurology 2002;58:S2-8.
ABSTRACT
| FULL TEXT
Effects of Polytherapy Compared With Monotherapy in Antiepileptic Drugs: An Animal Study
Roks et al.
J. Pharmacol. Exp. Ther. 1999;288:472-477.
ABSTRACT
| FULL TEXT
|
